Shang et al. carried out a retrospective investigation involving 229 cases of subarachnoid hemorrhage and found that, compared to the high-albumin group, patients with low serum albumin levels had an 18.51 times higher risk of adverse outcomes (OR: 18.51, 95% CI: 3.41–349.03). This evidence concerns the gene ALB and subarachnoid hemorrhage.